Regulation of PITX2 and ABCB1 in oncogenic multidrug resistance by tumorigenic HIF2 in VHL-deficient renal cancer cells

Lee W-K, Ow CJ, Schreiber T, Thevenod F (2022)
FASEB Journal 36 (Suppl. 1).

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Lee, Wing-KeeUniBi; Ow, Calista J; Schreiber, Timm; Thevenod, Frank
Abstract / Bemerkung
The tumour suppressor von Hippel-Lindau (VHL) is involved in ubiquitination and subsequent proteasomal degradation of hypoxia-inducible factors (HIFs). Under hypoxic conditions, HIFalpha-subunits are stabilized, leading to dimerization with HIFbeta and transactivation of genes for metabolism, survival and angiogenesis. Human renal cancer cells A498 are VHL-deficient and harbor stabilized HIF-2, whereas Caki-1 cells are VHL-intact and HIF-1-dominant. Previous studies demonstrated increased paired-like homeodomain transcription factor 2 (PITX2) and its target gene, the ABCB1 drug transporter, in A498 cells. The relationship between VHL, HIF, PITX2 and ABCB1 remains unclear. Transient transfection of A498 cells with HIF-1alpha or HIF-2alpha siRNA (25 nM, 72 h, >85% protein knockdown) attenuated PITX2 protein by up to 75% by immunoblotting and PITX2 promoter activity by ~40% in a luciferase reporter gene assay. Immunoprecipitation studies did not propose direct HIF-PITX2 protein-protein interaction. HIF-regulated PITX2 expression was proportional to ABCB1 expression, which was decreased at both mRNA (~20%) and protein (~70%) levels after HIF-1alpha or HIF-2alpha knockdown. Furthermore, HIF/PITX2 target gene CCND1 was reduced by >60%, but PITX2 targets LCN2 and WNT4 were increased >3-fold following transient HIF downregulation. HIF-2alpha siRNA was generally more effective than HIF-1alpha siRNA in altering PITX2 and its target genes. Conversely, in Caki-1 cells, HIF siRNA augmented PITX2 and ABCB1 mRNA and protein by ~1.5-fold and ~2-fold, respectively, with no significant changes in CCND1, LCN2 and WNT4. Polysome profiling show HIF-2alpha siRNA negatively impacts active translation of PITX2 and ABCB1 mRNA. Finally, HIF2 knockdown sensitizes A498 cells to cell death by the chemotherapeutic drug and ABCB1 substrate, doxorubicin (1 M, 24 h), as determined by trypan blue staining. In summary, these findings suggest PITX2 and ABCB1 are positively regulated by tumorigenic HIF2 in drug-resistant A498 cells whereas they are suppressed by HIF-1 in drug-sensitive Caki-1 cells. These data may provide better understanding of membrane transporters and possible upstream causes of multidrug resistance in different renal cancers. © FASEB.
Erscheinungsjahr
2022
Zeitschriftentitel
FASEB Journal
Band
36
Ausgabe
Suppl. 1
ISSN
1530-6860
Page URI
https://pub.uni-bielefeld.de/record/2963188

Zitieren

Lee W-K, Ow CJ, Schreiber T, Thevenod F. Regulation of PITX2 and ABCB1 in oncogenic multidrug resistance by tumorigenic HIF2 in VHL-deficient renal cancer cells. FASEB Journal. 2022;36 (Suppl. 1).
Lee, W. - K., Ow, C. J., Schreiber, T., & Thevenod, F. (2022). Regulation of PITX2 and ABCB1 in oncogenic multidrug resistance by tumorigenic HIF2 in VHL-deficient renal cancer cells. FASEB Journal, 36 (Suppl. 1). https://doi.org/10.1096/fasebj.2022.36.S1.R4734
Lee, W. - K., Ow, C. J., Schreiber, T., and Thevenod, F. (2022). Regulation of PITX2 and ABCB1 in oncogenic multidrug resistance by tumorigenic HIF2 in VHL-deficient renal cancer cells. FASEB Journal 36 .
Lee, W.-K., et al., 2022. Regulation of PITX2 and ABCB1 in oncogenic multidrug resistance by tumorigenic HIF2 in VHL-deficient renal cancer cells. FASEB Journal, 36 (Suppl. 1).
W.-K. Lee, et al., “Regulation of PITX2 and ABCB1 in oncogenic multidrug resistance by tumorigenic HIF2 in VHL-deficient renal cancer cells”, FASEB Journal, vol. 36 , 2022.
Lee, W.-K., Ow, C.J., Schreiber, T., Thevenod, F.: Regulation of PITX2 and ABCB1 in oncogenic multidrug resistance by tumorigenic HIF2 in VHL-deficient renal cancer cells. FASEB Journal. 36 , (2022).
Lee, Wing-Kee, Ow, Calista J, Schreiber, Timm, and Thevenod, Frank. “Regulation of PITX2 and ABCB1 in oncogenic multidrug resistance by tumorigenic HIF2 in VHL-deficient renal cancer cells”. FASEB Journal 36 .Suppl. 1 (2022).

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Quellen

PMID: 35551859
PubMed | Europe PMC

Suchen in

Google Scholar